United States · Wires & real time · Business Wire
BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026
SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from across its rapidly…
Read the full article on Business Wire Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.businesswire.com)
